Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kyle Malady currently holds 424,643.72 shares of DEXCOM INC (DXCM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kyle Malady has been a net seller of DXCM stock. They have purchased $0 and sold $2.8M worth of shares.
Kyle Malady's most recent insider trade was on Oct 8, 2026, when they sold 131.36 shares at $13.23 per share.
Kyle Malady serves as Executive at DEXCOM INC (DXCM). They have executed 108 insider transactions totaling $2.8M over their tenure at the company.
Kyle Malady holds the position of Executive at DEXCOM INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Kyle Malady has shown a selling trading pattern, with $0 in total purchases and $2.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kyle Malady was on Sep 15, 2026, when they sold $56.3K worth of VZ shares. This transaction involved 1,100 shares at $51.19 per share.
Kyle Malady currently owns 424,643.72 shares of DEXCOM INC (DXCM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kyle Malady's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kyle Malady has 108 Form 4 filings on record as an insider at DEXCOM INC.
Set alerts for Kyle Malady and 40,000+ other insiders.